Acute impairment of renal function in COVID-19: study on incidence, risk factors and mortality
Not Applicable
Recruiting
- Conditions
- Acute renal failureCoronavirus infection of unspecified locationB34.2
- Registration Number
- RBR-62y3h7
- Lead Sponsor
- Faculdade de Medicina de Botucatu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
suspected diagnosis of COVID-19
Exclusion Criteria
negative test for COVID-19; patients without diuresis control or at least two creatinine tests during hospitalization; pregnant women; age under 18; patients with advanced CKD (Cl Cr <30 ml / min; kidney transplant patients.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link acute kidney injury to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in observational studies?
How does acute kidney injury in RBR-62y3h7 compare to other SARS-CoV-2 observational trials in terms of mortality rates and risk factors?
What biomarkers are associated with acute kidney injury development in patients with coronavirus disease 2019 (COVID-19) and how do they inform patient stratification?
What are the potential adverse events and management strategies for acute kidney injury in hospitalized SARS-CoV-2 patients?
How do current standard-of-care treatments for SARS-CoV-2 infection influence the incidence and progression of acute kidney injury in observational cohorts?